Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Mineralys Therapeutics Inc., 3 years.
Mineralys Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | Mineralys Therapeutics Inc. | Open-market sale | −104,320 | $28.81 | $3,005,459 |
| Feb 19, 2026 | Mineralys Therapeutics Inc. | Grant or award | +6,200 | — | — |
| Feb 19, 2026 | Mineralys Therapeutics Inc. | Other | −6,200 | — | — |
| Feb 19, 2026 | Mineralys Therapeutics Inc. | Other | +6,200 | — | — |
| Nov 20, 2025 | Mineralys Therapeutics Inc. | Open-market sale | −1,000,000 | $43.35 | $43,350,000 |
| Mar 13, 2025 | Mineralys Therapeutics Inc. | Open-market purchase | +259,259 | $13.50 | $3,499,997 |
| Jul 24, 2024 | Mineralys Therapeutics Inc. | Open-market sale | −550,000 | $13.05 | $7,177,500 |
| Feb 14, 2023 | Mineralys Therapeutics Inc. | Derivative conversion | +4,314,093 | — | — |
| Feb 14, 2023 | Mineralys Therapeutics Inc. | Open-market purchase | +250,000 | $16.00 | $4,000,000 |
Questions about Brian Taylor Slingsby
What boards is Brian Taylor Slingsby on?
Brian Taylor Slingsby sits on the board of Mineralys Therapeutics Inc.
How long has Brian Taylor Slingsby served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.